Veeva Commercial Pulse: Revolutionizing Healthcare Professional Targeting
Veeva Systems, a global leader in cloud software for the life sciences industry, has announced the launch of its latest product, Veeva Commercial Pulse. This innovative data subscription service aims to enhance the accuracy of healthcare professional (HCP) access and targeting, particularly in commercial operations and data analytics teams. In an era where precise segmentation and targeting are critical for success, Veeva Commercial Pulse offers a comprehensive solution tailored for the life sciences sector.
Enhancing Segmentation and Targeting with Advanced Data
What sets Veeva Commercial Pulse apart is its ability to provide quarterly insights derived from over 500 million interactions within the Veeva Customer Relationship Management (CRM) system. This extensive data allows for a unique market view, ensuring that life sciences companies have access to the most complete, timely, and accurate HCP access data available. Whether it's for segmentation or engagement planning, Pulse presents concrete value by transforming raw data into actionable insights.
Peter Stark, Executive Vice President of Veeva Data Cloud, emphasizes the transformative nature of this product: "Pulse is a breakthrough data product that will greatly improve segmentation and targeting around the globe." The functionality offered by Pulse allows companies to refine their approach in engaging healthcare professionals, ultimately fostering enhanced relationships and improved business outcomes.
Broad Coverage Across Multiple Countries and Specialties
Veeva Commercial Pulse offers unmatched coverage with metrics available for over three million healthcare professionals across 102 specialties in 21 countries. This scale gives life sciences companies the ability to analyze markets effectively and engage with HCPs in a manner that resonates with their specific needs and preferences.
Additionally, the data is meticulously aggregated for data privacy, with metrics segmented by country, specialty, and even brick level, ensuring that clients can utilize this information without compromising HCP privacy. This focus on confidentiality is essential in today’s regulatory landscape, where data protection is paramount.
A Comprehensive Data Strategy for Life Sciences
The demand for precise and actionable data is at an all-time high in the life sciences industry. As organizations continue to navigate the complexities of healthcare marketing, Veeva Commercial Pulse serves as an integral component of a broader data strategy. It complements Veeva's existing data offerings, including Veeva OpenData, Veeva Link, and Veeva Compass, creating a synergistic ecosystem designed to support clients in achieving their commercial objectives.
With Pulse set to begin releasing quarterly data for 2025 starting this April, clients will have timely access to metrics that inform their strategy not just in established markets such as the United States, Canada, and Germany, but also in emerging regions like Brazil, Mexico, and South Korea. Veeva has future plans to expand this service into additional countries throughout Asia and Europe, continuing its commitment to global accessibility in the healthcare sector.
A Commitment to Innovation and Customer Success
Veeva Systems is dedicated to helping its clients succeed through innovation and product excellence. With over 1,000 customers, including the largest biopharmaceutical companies and emerging biotech firms, Veeva continues to set industry standards. As a Public Benefit Corporation, Veeva emphasizes its commitment to balancing the interests of all stakeholders involved.
In conclusion, Veeva Commercial Pulse is poised to redefine how companies approach HCP access and engagement. By providing actionable insights derived from vast datasets, it empowers organizations to make informed strategic decisions and build stronger connections in the healthcare landscape. For more information, visit the Veeva website at
veeva.com/Pulse.